Article metrics

Extended report
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
Free

 

Online download statistics by month:

Online download statistics by month: October 2014 to April 2021

AbstractFullPdf
Oct 2014338443
Nov 20141066193250
Dec 20142055121286
Jan 20151063101198
Feb 201571369109
Mar 201548892121
Apr 20152714063
May 20151724043
Jun 20151913562
Jul 20151442540
Aug 20151003025
Sep 20151882733
Oct 2015951615
Nov 20151442831
Dec 20151121515
Jan 20161592628
Feb 20161302731
Mar 20161583546
Apr 20161575144
May 20161554154
Jun 20161054442
Jul 20161534152
Aug 20161143132
Sep 20161403645
Oct 20161124243
Nov 20161335843
Dec 20161233629
Jan 20171365034
Feb 2017496733
Mar 20174011161
Apr 20174518676
May 20173915456
Jun 20176712954
Jul 201722313147
Aug 201723813640
Sep 201724212035
Oct 201727413030
Nov 201723011938
Dec 201750237530
Jan 201838128935
Feb 201829117135
Mar 201829820529
Apr 201825316937
May 201826817635
Jun 201826818123
Jul 201825116829
Aug 201827421121
Sep 201820414117
Oct 201829018822
Nov 201823021628
Dec 201819718719
Jan 201919218117
Feb 201917816816
Mar 201918615440
Apr 201917914628
May 201912210142
Jun 20191108828
Jul 20191119031
Aug 201910910124
Sep 2019857529
Oct 20191089929
Nov 201912510829
Dec 201915610421
Jan 202011310642
Feb 20201118923
Mar 202011210129
Apr 2020887720
May 20201079345
Jun 2020635415
Jul 2020948625
Aug 2020353327
Sep 2020684732
Oct 2020995461
Nov 2020855234
Dec 20201166224
Jan 2021684026
Feb 2021793929
Mar 2021915221
Apr 2021986332
Total1715777773506